Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 27, 2024
- Accession no.
- 0001415889-24-027799
- Filed
- Nov 27, 2024
- Trade date
- Nov 25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.73M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Common Stock | MOption exerciseAcquired | +7,500 | $102.11 | +$765,825 | 7,500 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −398 | $368.76 | −$146,766.48 | 7,102 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −500 | $369.46 | −$184,730 | 6,602 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −300 | $371.15 | −$111,345 | 6,302 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −1,455 | $372.20 | −$541,551 | 4,847 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −3,208 | $373.17 | −$1,197,129.36 | 1,639 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −1,116 | $374.15 | −$417,551.4 | 523 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −423 | $375.07 | −$158,654.61 | 100 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −100 | $376.18 | −$37,618 | 0 | Indirect | |
| Nov 25, 2024 | Common Stock | MOption exerciseAcquired | +2,500 | $111.00 | +$277,500 | 2,500 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −284 | $368.84 | −$104,750.56 | 2,216 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −532 | $372.09 | −$197,951.88 | 1,684 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −1,082 | $373.39 | −$404,007.98 | 602 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −402 | $374.35 | −$150,488.7 | 200 | Indirect | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −200 | $375.12 | −$75,024 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 12,000 | Indirect | |
| Nov 25, 2024 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 37,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.